Dartmouth reconfigures top-tier leadership: Vahdat gets enhanced deputy director role, Dragnev becomes chief of heme onc section, deputy director of clinical affairs

Cancer leaders play “musical chairs” as executive jobs fill at top cancer centers
Lee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida

Change swept through executive offices at cancer centers in recent weeks, shifting top leadership at the University of Texas MD Anderson Cancer Center, Duke Cancer Institute, and the University of Florida.

Heidi Overton selected as FDA commissioner; Jared Seehafer named inaugural Deputy Commissioner for Technology and AI

As part of a sweep of leadership changes at FDA, Heidi Overton, deputy director of the White House Domestic Policy Council, has been nominated to the role of FDA commissioner.

September 11, 2026

Vol.52 No.33

By Claire Marie Porter

In Brief

Samuel Kaffenberger named deputy director for cancer clinical services at U-M Rogel Cancer Center

Samuel Kaffenberger was named deputy director for cancer clinical services at the University of Michigan Rogel Cancer Center.

September 11, 2026

Vol.52 No.33

In Brief

Adam Bacik named CEO of planned MUSC cancer hospital

Adam Bacik was appointed CEO of the Medical University of South Carolina’s new comprehensive cancer hospital in Charleston.

September 11, 2026

Vol.52 No.33

In Brief

Rogel Cancer Center founder Max Wicha to retire after 46 years

After 46 years, Max S. Wicha, founding director of the University of Michigan Rogel Cancer Center, will retire from the University of Michigan and move to emeritus status.

September 11, 2026

Vol.52 No.33

In Brief

Raghu Kalluri joins UTMB as cancer center leader, chief scientific officer

The University of Texas Medical Branch appointed Raghu Kalluri as senior vice president, executive director of the UTMB Cancer Center, and chief scientific officer, effective Sept. 1.

September 11, 2026

Vol.52 No.33

Dartmouth reconfigures top-tier leadership: Vahdat gets enhanced deputy director role, Dragnev becomes chief of heme onc section, deputy director of clinical affairs

YOU MAY BE INTERESTED IN

Cancer leaders play “musical chairs” as executive jobs fill at top cancer centers
Lee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida

Heidi Overton selected as FDA commissioner; Jared Seehafer named inaugural Deputy Commissioner for Technology and AI

Samuel Kaffenberger named deputy director for cancer clinical services at U-M Rogel Cancer Center

Adam Bacik named CEO of planned MUSC cancer hospital

Rogel Cancer Center founder Max Wicha to retire after 46 years

Raghu Kalluri joins UTMB as cancer center leader, chief scientific officer

Renew today!

Subscriber content

Never miss an issue!

Login

Dartmouth reconfigures top-tier leadership: Vahdat gets enhanced deputy director role, Dragnev becomes chief of heme onc section, deputy director of clinical affairs

YOU MAY BE INTERESTED IN

Cancer leaders play “musical chairs” as executive jobs fill at top cancer centersLee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida

Heidi Overton selected as FDA commissioner; Jared Seehafer named inaugural Deputy Commissioner for Technology and AI

Samuel Kaffenberger named deputy director for cancer clinical services at U-M Rogel Cancer Center

Adam Bacik named CEO of planned MUSC cancer hospital

Rogel Cancer Center founder Max Wicha to retire after 46 years

Raghu Kalluri joins UTMB as cancer center leader, chief scientific officer

Never miss an issue!

Login

Cancer leaders play “musical chairs” as executive jobs fill at top cancer centers
Lee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida